3Rosen G. Management of malignant bone tumors in children and adolescents. Pediatr Clin North Am, 1976,23(2):183-213. 被引量：1
4Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastase: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med, 1995,1(2):149-153. 被引量：1
5Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local- regional disease in women with operable breast cancer: findings from national surgical adjuvant breast and bowel project B-18.J Clin Oncol, 1997, 15(7):2483-2493. 被引量：1
6Hutcheon AW, Heys SD, Sarkar TK. Neoadjuvant docetaxel in locally advanced breast cancer. Breast Cancer Res Treat, 2003, 79(Suppl 1):19-24. 被引量：1
7Pierga JY, Mouret E, Laurence V, et al. Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. the role of clinical response.Eur J Cancer, 2003, 39(8):1089-1096. 被引量：1
8Faneyte IF, Schrama JG, Peterse JL, et al. Breast cancer response to neoadjuvant chem otherapy: predictive markers and relation with outcome.Br J Cancer, 2003, 88(3):406-412. 被引量：1
9Tulbah AM, Ibrahim EM, Ezzat AA, et al. HER-2/Neu overexpression does not predict response to neoadjuvant chemotherapy or prognosticate survival in patients with locally advanced breast cancer. Med Oncol, 2002, 19(1):15-23. 被引量：1
10Lee SH, Chung MA, Quddus MR, et al. The effect of neoadjuvant chemotherapy on estrogen and progesterone receptor expression and hormone receptor status in breast cancer. Am J Surg, 2003, 186(4):348-350. 被引量：1
二级参考文献31
1Mattern J, Koommagi R, Volta M. Biological characterization of subgroups of squamous cell lung carcinomas[J]. Clin Cancer Res, 1999,5 (6) : 1459. 被引量：1
2Miwa M,Ura M, Nishida M, et al. Design of novel oral fluoropyrimidine carbamate capecitabine, which generates 5'-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue[J]. Eur J Cancer, 1998,34(8) :1274. 被引量：1
3Takebayashi Y,Akiyama S,Akiba S, et al. Clinicopathologic and prognostic significance of an angiogenic factor,thymidine phosphorylase in human colorectal carcinoma[J]. Natl Cancer Inst, 1996,88(16) :210. 被引量：1
4Koizumi W, Saigenji K, Nakamaru N, et al. Prediction of response to 5'-deoxy-5-fluorouridine (5'-DFUR) in patients with inoperable advance gastric cancer by immunostaining of thymidine phosphorylase/platelet-derived endothelial cell growth factor[J]. Oncology, 1999,56(3) :215. 被引量：1
5Osaki M, Sakatani T, Okamoto E, et al. Thymidine phosphorylase expression results in a decrease in apoptosis and increase in intratumoral microvessel density in human gastric carcinomas[J]. Virchows Arch ,2000,437(1):31. 被引量：1
6Okamoto E, Osaki M, Kase S, et al. Thymidine phosphorylase expression causes both the increase of intratumoral microvessel and decrease of apoptosis in human esophageal carcinomas[J]. Pathol Int, 2001,51 (3) : 158. 被引量：1
7Fukushima Y, Inagawa H, Yoshimura H, et al. Alteration of phyrimidine nudeoside phosphorylase activity in colorecter tumor tisses by preoperative administration of 5'-deoxy-5-fluorouridine [J]. Biotherapy, 1998, 12 ( 5 ) :829. 被引量：1
8Semiglazova Tiu,Gershanovich ML. Xeloda(capecetabine) in the treatment of disseminated breast cancer after failure with anthracyclines and taxanes[J]. Voprosy Onkologii ,2001,47(3) :298. 被引量：1
9Smith IE,Walsh G,Jones A,et al.High complete remission rates with prmary neosdjtvant infusional chemotherapy for large early breask cancer.J Clin Oncol,1995:13(2):124. 被引量：1
10Ellis FA,et al.Freoperative seoadjsvant canochelipy for early breast clincer indocts apoptesis .Pric Am Meet.Ain Soc.Clin Oncok,1996:15A:112. 被引量：1
6BPdSTOW RE, TOMACRUZ RS, AMSTRONG DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinumera: a meta-analysis[J]. Clin Oncol, 2002, 20(5): 1248. 被引量：1
7GERSHENSON D. Treatment of advanced ovarian cancer [M]. Alexandria, VA: ASCO Educational Book, 2000: 130. 被引量：1
8COUKOS G, RUBIN SC. Chemotherapy resistanee in ovarian cancer: new moleeular pers pectives[J]. Obstetand Gyneeol, 1998, 91 (5):783-792. 被引量：1
9LOSA JH, PARADA COBO C, VINIEGRA JG, et al. Role of the P38MAPK pathway in cisplatin-based therapy [J]. Oncogene, 2003, 22(26): 3998-4006. 被引量：1
10PETER E, SCHWARTZ, THOMAS J RUTHERFORD, JOSEPH T CHAMBERS, et al. Neo-adjuvant chemotherapy for advanced ovarian cancer long-term survival[J]. Gynecologic Oncology, 1999, 72(1): 93-99. 被引量：1
